Dopa-responsive parkinsonism without cerebellar ataxia in spinocerebellar ataxia 6
Clinical Parkinsonism & Related Disorders · 2025 · 12 · 100322
DOI: 10.1016/j.prdoa.2025.100322 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Parkinsonism & Related Disorders, 2025. Verfasst von Shun Yoshida und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, NHO Yonezawa National Hospital, 26100-1, Misawa, Yonezawa, Yamagata 992-1202, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
•While SCA6 patients mainly show pure cerebellar ataxia, some cases have parkinsonism.•In SCA6 patients, levodopa responsivity to parkinsonism is seldom reported.•We show an SCA6 patient with dopa-responsive parkinsonism without cerebellar ataxia.
Autor:innen und Institutionen
- Department of Neurology, NHO Yonezawa National Hospital, 26100-1, Misawa, Yonezawa, Yamagata 992-1202, Japan.
- Department of Neurology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
- Department of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Zitieren
APA
Yoshida, S., Takahashi, T., Suzuki, N., & Tobita, M. (2025). Dopa-responsive parkinsonism without cerebellar ataxia in spinocerebellar ataxia 6. Clinical Parkinsonism & Related Disorders, 12, 100322. https://doi.org/10.1016/j.prdoa.2025.100322
Vancouver
Yoshida S, Takahashi T, Suzuki N, Tobita M. Dopa-responsive parkinsonism without cerebellar ataxia in spinocerebellar ataxia 6. Clinical Parkinsonism & Related Disorders. 2025;12:100322. doi:10.1016/j.prdoa.2025.100322
BibTeX
@article{Yoshida2025,
author = {Yoshida, Shun and Takahashi, Toshiyuki and Suzuki, Naoki and Tobita, Muneshige},
title = {Dopa-responsive parkinsonism without cerebellar ataxia in spinocerebellar ataxia 6},
journal = {Clinical Parkinsonism & Related Disorders},
year = {2025},
volume = {12},
pages = {100322},
doi = {10.1016/j.prdoa.2025.100322}
}
EUVIMED